SUMMARY
machinery. This arrest in DNA repair (by inhibiting PARP-1) in PAH-PASMC will enhance 244 DNA damage, thus the cell will react to overload of DNA damage by stopping proliferation and 245 triggering apoptosis. 246 247 miR-223 promotes proliferation and resistance to apoptosis in PAH-PASMCs 248
To study the effect of miR-223 on PASMCs proliferation and apoptosis in vitro, cultured human 249 PAH-PASMCs were exposed to 10% FBS (a condition known to promote proliferation) or 0.1% 250 FBS (a "starvation" condition that promotes apoptosis). As expected, PAH-PASMC exhibited 251 increased proliferation, as well as less apoptosis as compared to control cells ( Figure 2B with a random antagomiR (AntagomiR-Ctrl) ( Figure 2B ). They also exhibit a resistance to 259 starvation-induced apoptosis ( Figure 2B ). On the other hand, PAH-PASMCs (n=5) treated with 260 miR-223 mimic show less proliferation level and higher apoptosis rates ( Figure 2B Figure 3A ). 272 273
We observed that the local delivery of synthetic miR-223 in MCT-PAH rats improves overall 274 survival compared to MCT-PAH rats nebulized with the random miRNA (mimic-Ctrl) ( Figure  275 3B). Ectopic delivery of miR-223 mimic was also associated with a reduction in mPAP as well 276 as with RV systolic pressure when compared to MCT-PAH rats treated with a non-specific 277 synthetic RNA molecules ( Figure 4A ). These effects were associated with a significant increase 278 in cardiac output and a reduction of total pulmonary resistance ( Figure 4A ), confirming the 279 therapeutic potential of restoring miR-223 levels in PAH. Beneficial effects were also found in 280 the RV, as the hypertrophy was decreased upon mimic-223 treatment (n= at least 10 per group) 281 ( Figure 4B ). In order to determine whether the reduced vascular remodeling was accountable for 282 the improvement in hemodynamic parameters allowed by miR-223 delivery, we measured PA 283 medial wall thickness after an H&E stain. We observed that animals treated with the synthetic 284 miR-223 displayed a significant reduction in medial thickness of small and distal PAs ( Figure  285 5A). Furthermore, rats that received synthetic miR-223 had decreased muscularization of their 286 distal PAs and fewer were fully occluded. We also observed an increase in low-resistance non-287 muscularized vessels as compared to MCT and random miRNA (mimic-Ctrl) treated rats ( Figure  288 5A). The decrease in vascular remodeling in rats treated with synthetic miR-223 is due to a 289 decrease in proliferation and increase in apoptosis levels within the vessel wall, as assessed by 290
Ki67 and TUNEL, respectively (
Figure 5B We demonstrated that the normoxic activation of HIF-1α induces miR-223 downregulation 302 ( Figure 1B ) and subsequent PARP-1/DNA damage signaling exacerbation ( Figure 1C and 2A) ; 303 establishing a new link between these two crucial elements in PAH physiopathology. We 304 demonstrated that restoring miR-223 in PAH-PASMCs decreased PARP-1 expression and thus 305 DNA damage repair, promoting PAH-PASMC apoptosis and decreasing their proliferation 306 (Figure 2 ). In vivo, we showed that MCT-PAH rats treated with ectopic increase of miR-223 307 levels in their lungs exhibited decreased mortality, improvement in pulmonary hemodynamic 308 parameters, as well as decreased RV hypertrophy and vascular remodeling (Figures 4 and 5) . 309 310
In the current study, we propose for the first time that HIF-1 implication in PAH is not 311 exclusively directly related to apoptosis and proliferation as previously thought (2, 32 measurements were performed by right heart catheterization (n=10 to 13 rats per group). We 564
showed that restoring miR-223 expression in the lungs decreased mean pulmonary arterial 565 pressure (mPAP) and right ventricle (RV) systolic pressure, increased cardiac output (CO) and 566 consequently decreased total pulmonary resistance (TPR). B) Increased miR-223 expression also 567 led to decreased RV hypertrophy as assessed by the Fulton Index (RV/left ventricle and septum 568 (LV+S)) (n=10 to 13 rats per group). *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001 569 570
Figure 5: Restoring miR-223 levels decreases lung vascular remodeling. A) We measured 571 vascular remodeling by calculating the percentage of the PA wall area on total artery area in 10 572 arteries per animal in 10 to 13 animals per group. We also measured the amount (in %) of 573 partially muscularized and fully muscularized arteries (n=10 to 13). Mir-223 treatment decreased 574 mean vascular remodeling and increased the amount of non-muscularized arteries compared to 575 rats treated with the random mimic (mimic-Ctrl 
